Cargando…

Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials

IMPORTANCE: Expansion of opioid use disorder treatment is needed, particularly in rural communities. OBJECTIVE: To evaluate technology-assisted buprenorphine (TAB) efficacy (1) over a longer period than previously examined, (2) with the addition of overdose education, and (3) among individuals resid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sigmon, Stacey C., Peck, Kelly R., Batchelder, Sydney R., Badger, Gary J., Heil, Sarah H., Higgins, Stephen T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534272/ https://www.ncbi.nlm.nih.gov/pubmed/37755833 http://dx.doi.org/10.1001/jamanetworkopen.2023.31910

Ejemplares similares

Assessment of Disparities in Diabetes Mortality in Adults in US Rural vs Nonrural Counties, 1999-2018
por: Dugani, Sagar B., et al.
Publicado: (2022)

Learning and Use of eHealth Among Older Adults Living at Home in Rural and Nonrural Settings: Systematic Review
por: Airola, Ella
Publicado: (2021)

Reconsidering Rural-Nonrural College Enrollment Gaps: The Role of Socioeconomic Status in Geographies of Opportunity
por: Wells, Ryan S., et al.
Publicado: (2023)

GEROFIT TO HOME: REDUCING BARRIERS TO GROUP EXERCISE TO RURAL AND NONRURAL OLDER ADULTS IN A SUCCESSFUL FASHION
por: Gregor, Neil, et al.
Publicado: (2022)

Perinatal Health Outcomes Across Rural and Nonrural Counties Within a Single Health System Catchment
por: Lemas, Dominick J., et al.
Publicado: (2023)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients
por: Hall, Sharon M, et al.
Publicado: (2018)

Mind the gap: what explains the rural-nonrural inequality in diarrhoea among under-five children in low and medium-income countries? A decomposition analysis
por: Fagbamigbe, A. F., et al.
Publicado: (2021)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

The Impact of the Covid-19 Pandemic on Smoking Among Vulnerable Populations
por: Wiley, Rhiannon C, et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: Initial feasibility
por: Streck, Joanna M., et al.
Publicado: (2018)

Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US
por: Han, Beth, et al.
Publicado: (2021)

Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
por: Sue, Kimberly L., et al.
Publicado: (2023)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Comparative analgesic efficacy of buprenorphine or clonidine with bupivacaine in the caesarean section
por: Agarwal, Kiran, et al.
Publicado: (2010)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2023)

Factors in rural community buprenorphine dispensing
por: Major, Erin G., et al.
Publicado: (2022)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic
por: Chen, Annie Y., et al.
Publicado: (2022)

Lower buprenorphine elimination rate constant is associated with lower opioid use
por: Elarabi, Hesham Farouk, et al.
Publicado: (2022)

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials
por: Higgins, Stephen T., et al.
Publicado: (2020)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access
por: Treitler, Peter, et al.
Publicado: (2023)

Adoption of Emergency Department–Initiated Buprenorphine for Patients With Opioid Use Disorder: Secondary Analysis of a Cluster Randomized Trial
por: Gao, Evangeline, et al.
Publicado: (2023)

Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids
por: Claypool, Anneke L., et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
por: Tanz, Lauren J., et al.
Publicado: (2023)

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
por: Stein, Bradley D., et al.
Publicado: (2023)

Development of a Model to Estimate the Optimal Number of Oocytes to Attempt to Fertilize During Assisted Reproductive Technology Treatment
por: Correia, Katharine F. B., et al.
Publicado: (2023)

Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
por: Solmeyer, Anna R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ioedbikk7vmctl9nkueqg55ige